#95 Dr. Jon Berner discusses his unique lens to reimagining how we treat complex mental health conditions with both precision and humanity.

Neuroveda Podcast for Complex Health

Summary

In this episode of the Neuroveda podcast, host Gillian Ehrlich engages with Dr. John Berner, a Harvard-trained psychologist and neuroscientist, to explore the intricate relationship between mind and body in the context of mental health. They discuss the limitations of traditional medical silos, the importance of cellular communication, and the role of hormones in health. Dr. Berner introduces the concept of intersectionality in psychiatric treatment, emphasizing the need for personalized approaches. The conversation also delves into innovative treatments like rapamycin and the significance of understanding cellular interactions through advanced technologies.

Takeaways

Mind-body medicine should not separate mental and physical health.

The shift from Newtonian to quantum thinking is crucial in medicine.

Cellular communication is a localized and complex process.

Hormones play a central role in coordinating bodily functions.

Understanding evolutionary constraints can inform health practices.

Intersectionality is key in treating mental health conditions.

Rapamycin shows promise in extending lifespan and improving health.

Eavesdropping on cellular conversations can enhance treatment strategies.

Innovative technologies can measure cellular responses effectively.

Biology is complex and cannot be simplified into binary categories.

Bio

Dr. Jon Berner, a Harvard-trained psychologist, UCLA-trained neuroscientist and physician, and University of Washington–trained psychiatrist. With over 25 years in clinical practice, his work bridges rigorous neuroscience, psychiatry, and compassionate patient care. Dr. Berner’s publications span from the cognitive effects of cocaine and memory in schizophrenia to pioneering treatments with ketamine, rapamycin, and novel metabolomic approaches for mood and pain disorders. He brings a unique lens—uniting neural networks, biochemistry, and clinical psychiatry—to reimagine how we treat complex mental health conditions with both precision and humanity.